Arrow International PICC kits and stylets recalled for compromised sterility and drug ineffectiveness
Arrow International PICC kits recalled for sterility concerns
Arrow International recalled several PICC (peripherally inserted central catheter) kits and stylets because they contain injectable medications from a supplier with quality issues. The medications—lidocaine, bupivacaine, and saline—may be ineffective or contaminated, which could cause serious injury if used.
- Check if you have any affected PICC kits or stylets listed in this recall (lot numbers and model numbers available on FDA.gov).
- Do not use affected kits; contact your healthcare provider or hospital for replacements.
- Report any adverse effects or injuries to the FDA MedWatch program or your healthcare provider.
Lidocaine, Bupivacaine, and 0.9% sodium chloride, the subject of a supplier recall, were included into kits and sets. The supplier was found to have quality issues and limited reports of drug ineffectiveness, and if sterility of a water-based injectable product is compromised this could lead to serious or life-threatening injuries.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-2367-2026More Arrow recalls
- FDA-Device2026-06-24Arrow International hemodialysis kits recalled for contaminated anesthetic and saline solutions
- FDA-Device2026-06-24Arrow International PI CVC kits recalled for compromised sterility and drug ineffectiveness
- FDA-Device2026-06-24Arrow International PICC and JACC catheter kits recalled for contaminated anesthetic and saline components
- FDA-Device2026-06-24Arrow International Pacing PSI Kits recalled for potential drug ineffectiveness and sterility compromise
- FDA-Device2026-06-24Arrow International paracentesis kits recalled for compromised sterility and drug ineffectiveness
Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief